Open Access

Table 2

Leukocyte concentration and composition in whole blood (WB), LP-PRP, and APS.

PRPs and Blood
components
Healthy volunteers (HV)
Knee osteoarthritis (KOA)
Leukocyte
concentration
(×103/ml)
Cell counts (×103/ml) and composition (%)
Leukocyte
concentration
(×103/ml)
Cell counts (×103 /ml) and composition (%)
Lymphocyte Monocyte Neutrophil Lymphocyte Monocyte Neutrophil
Whole blood 4.3 ± 1.1 1.4 ± 0.3
(33.3 ± 8.4)
0.2 ± 0.09
(5.9 ± 2.0)
2.7 ± 1.1
(60.7 ± 9.0)
5.9 ± 1.0 1.7 ± 0.3
(29.2 ± 4.7)
0.3 ± 0.1
(6.5 ± 2.5)
3.8 ± 0.8
(64.2 ± 4.1)
LP-PRP 1.9 ± 0.8 1.7 ± 0.7
(89.7 ± 3.0)
0.1 ± 0.06
(5.4 ± 2.8)
0.08 ± 0.09
(3.7 ± 2.9)
2.4 ± 1.1 2.3 ± 0.8
(84.8 ± 5.4)
0.2 ± 0.1
(7.5 ± 6.5)
0.2 ± 0.2
(7.5 ± 4.7)
APS 44.1 ± 7.5 20.6 ± 3.2
(47.9 ± 10.7)
5.0 ± 3.2
(11.8 ± 8.0)
18.4 ± 9.4
(40.1 ± 14.8)
26.6 ± 10.5 13.1 ± 3.8
(52.1 ± 15.3)
2.4 ± 1.1
(9.2 ± 2.7)
11.1 ± 7.0
(38.5 ± 16.1)

Data are presented as the mean ± SD. LP-PRP, leukocyte-poor platelet-rich plasma; APS, autologous protein solution.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.